A. Ciociola

发表

Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration.

J. Gardner, A. Ciociola, M. Robinson, 2002, Journal of applied physiology.

Synergy between low‐dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal‐induced heartburn

J. Gardner, A. Ciociola, M. Robinson, 2001, Alimentary pharmacology & therapeutics.

A double-masked, placebo-controlled study of the efficacy and safety of premeal ranitidine in the prevention or reduction of heartburn

K. Buaron, A. Ciociola, J. Payne, 1998 .

Ranitidine Bismuth Citrate Plus Clarithromycin: A Dual Therapy Regimen for Patients with Duodenal Ulcer

A. Ciociola, S. Sontag, A. Heath, 1998, Helicobacter.

Control of Nocturnal Gastric Acidity: A Role for Low Dose Bedtime Ranitidine to Supplement Daily Omeprazole

J. Gardner, A. Ciociola, M. Robinson, 2002, Digestive Diseases and Sciences.

The Continued Use of Placebo-Controlled Clinical Trials in the Study of Peptic Ulcer Disease: A Sponsor Perspective

D. D. Webb, A. Ciociola, D. Mcsorley, 1996 .

A Study of the Nonprescription Drug Consumer's Understanding of the Ranitidine Product Label and Actual Product Usage Patterns in the Treatment of Episodic Heartburn

A. Ciociola, K. Pappa, J. A. McGuire, 2001, American journal of therapeutics.

Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides

A. Zinsmeister, C. Twomey, L. Miller, 1989, Digestive Diseases and Sciences.

Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.

G. Hortobagyi, F. Holmes, A. Ciociola, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ranitidine, 75 mg, over‐the‐counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro‐oesophageal reflux

A. Ciociola, J. Lavine, S. Orenstein, 2002, Alimentary pharmacology & therapeutics.

Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection

D. D. Webb, A. Ciociola, J. Walsh, 1996, Alimentary pharmacology & therapeutics.

Efficacy of Oral Ondansetron in the Prevention of Emesis in Outpatients Receiving Cyclophosphamide-based Chemotherapy

A. Ciociola, Alex Chang, N. Tchekmedyian, 1993, Annals of Internal Medicine.

Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated.

J. Palmer, A. Ciociola, D. Sykes, 1999 .

How Drugs are Developed and Approved by the FDA: Current Process and Future Directions

Prasad Kulkarni, Lawrence B Cohen, A. Ciociola, 2014, The American Journal of Gastroenterology.

The FDA's Generic-Drug Approval Process: Similarities to and Differences From Brand-Name Drugs

A. Ciociola, C. Kefalas, 2011, The American Journal of Gastroenterology.

An Alternative Non‐Macrolide, Non‐Imidazole Treatment Regimen for Curing Helicobacter pylori and Duodenal Ulcers: Ranitidine Bismuth Citrate Plus Amoxicillin

D. Graham, A. Ciociola, D. Sykes, 1998, Helicobacter.

Dual and triple therapy regimens of antisecretory agents and antibiotics for the eradication of Helicobacter pylori: an overview.

D. D. Webb, A. Ciociola, K. Turner, 1996, Scandinavian journal of gastroenterology. Supplement.

Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated

J. Palmer, A. Ciociola, D. Sykes, 1999, American Journal of Gastroenterology.

Evaluation of the teratogenicity of morphine sulfate administered via a miniature implantable pump.

A. Ciociola, R. Gautieri, Ronald F. GautieriX, 1983, Journal of pharmaceutical sciences.

by in vivo gastric autotitration Measurement of meal-stimulated gastric acid secretion

A. Asai, J. Brouillette, J. Gardner, 2015 .

Ranitidine 150 MG rapidly increases pain threshold and decreases symptom severity with acid infusion in patients with functional heartburn

A. Ciociola, P. Miner, H. Proskin, 2003 .

How the FDA Manages Drug Safety With Black Box Warnings, Use Restrictions, and Drug Removal, With Attention to Gastrointestinal Medications

A. Ciociola, E. Ehrenpreis, P. Kulkarni, 2012, The American Journal of Gastroenterology.

Teratogenic and Behavioral Anomalies Induced by Acute Exposure of Mice to Ethanol and Their Possible Relation to Fetal Brain DNA Synthesis

A. Ciociola, R. Gautieri, 1988, Pharmaceutical Research.

GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man

A. Zinsmeister, C. Twomey, L. Miller, 1990, Digestive Diseases and Sciences.

Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn

A. Ciociola, M. Robinson, P. Miner, 2002, Alimentary pharmacology & therapeutics.

Nonprescription Doses of Ranitidine Are Effective in the Relief of Episodic Heartburn

A. Ciociola, K. Pappa, M. Sirgo, 2001, American journal of therapeutics.